|Articles|July 21, 2022
Worldwide Clinical Trials Launches Large Molecule Services
New services added to CRO’s early phase business to better serve customers.
Advertisement
Worldwide Clinical Trials, Inc. has announced the extension of its service offerings to include large molecule capabilities, now integrated into its preexisting clinical pharmacology and pharmacokinetics business unit. Capabilities include pharmacodynamic studies, pharmacokinetics, biomarker assays, and immunogenicity testing.
Read more about the new service offerings
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5